Summary
The Progressive Corporation (PGR) reported a strong second quarter for 2020, with significant increases in net income and comprehensive income attributable to Progressive, up 83% and 88% respectively, compared to the same period in the prior year. This robust performance was driven by a combination of factors, including strong underwriting results and substantial gains in investment portfolios. The company benefited from reduced auto accident frequency due to COVID-19 restrictions, leading to a decrease in loss and loss adjustment expenses. While expenses were impacted by policyholder credits and increased bad debt provisions related to pandemic relief efforts, the overall underwriting margin improved significantly.
Financial Highlights
35 data points| Revenue | $10.97B |
| Interest Expense | $56.40M |
| Net Income | $1.79B |
| EPS (Basic) | $3.05 |
| EPS (Diluted) | $3.04 |
| Shares Outstanding (Basic) | 584.80M |
| Shares Outstanding (Diluted) | 587.20M |
Key Highlights
- 1Net income attributable to Progressive surged by 83% to $1.79 billion for the second quarter of 2020 compared to $979.4 million in Q2 2019.
- 2Total revenues increased by 16% to $10.97 billion in the second quarter of 2020, up from $9.45 billion in the prior year period.
- 3The company's underwriting profit margin improved to 12.3% in Q2 2020 from 9.6% in Q2 2019, largely due to decreased loss and loss adjustment expenses from lower auto accident frequency.
- 4Investments portfolio saw a significant rebound, with a total portfolio fair value of $43.8 billion at June 30, 2020, up from $36.8 billion at June 30, 2019.
- 5Net premiums written grew by 11% to $10.14 billion in the second quarter of 2020.
- 6The company declared common share dividends of $0.10 per share for both the first and second quarters of 2020, totaling $58.5 million each quarter.
- 7While underwriting performance was strong, the company issued $1 billion in credits to personal auto policyholders and recorded a $120 million increase in the allowance for doubtful accounts due to billing leniency efforts related to COVID-19.